EW Edwards Lifesciences stock outlook 2026: TAVR Sapien market leadership, Critical Care divestiture to BD, TMTT mitral and tricuspid therapy pipeline, Japan reimbursement opportunity, Medtronic CoreValve competition.
SYK Stryker stock outlook 2026: Mako robotic surgery installed base advantage, knee and hip implant market share, Vocera acquisition integration, emerging market growth, supply chain normalization, and scenario analysis.
HUM Humana stock outlook 2026: Medicare Advantage star-rating litigation, CMS reimbursement cuts, medical loss ratio recovery, CenterWell primary care expansion, enrollment headwinds, and scenario analysis.
MET MetLife stock outlook 2026: Japan and Korea Asia expansion, pension risk transfer dominance, variable annuity exit, group benefits leadership, capital return, and interest rate scenarios.